Though recent studies demonstrated a role of Nrf2 in glioma invasion [15], angiogenesis [16,17], the self-renewal of glioma stem cells [18], and temozolomide-mediated cytotoxicity [19,20] its precise role in tumor progression remains largely controversial. Here, NFE2L2 is linked to central nervous system cancer.